L4 CCBs: Dihydropyridines vs Non-Dihydropyridines

Edit Answers
123456789101112131415
Across
  1. 1. Inotropy Effect of non-dihydropyridines that decreases the force of heart contractions
  2. 4. Rate Non-dihydropyridines reduce this by slowing conduction through the AV node
  3. 5. Verapamil and Diltiazem reduce this in the heart, unlike dihydropyridines
  4. 6. Condition treated by dihydropyridines due to their vasodilatory effects
  5. 8. Tachycardia A common side effect of dihydropyridines due to potent vasodilation
  6. 9. The primary effect of dihydropyridines on blood vessels
  7. 12. Edema A common side effect of dihydropyridines, especially in lower limbs
  8. 13. Channels The calcium channels blocked by both dihydropyridines and non-dihydropyridines
  9. 14. A long-acting dihydropyridine used for hypertension management
  10. 15. A non-dihydropyridine CCB used to reduce heart rate and contractility
Down
  1. 1. Class of CCBs that primarily affect heart rate and contractility
  2. 2. Node The node where non-dihydropyridines primarily exert their effects
  3. 3. Class of CCBs primarily affecting vascular smooth muscle, causing vasodilation
  4. 7. A non-dihydropyridine with intermediate effects on both heart rate and vasodilation
  5. 10. Condition treated by non-dihydropyridines due to their effects on heart rate
  6. 11. Chronotropy Effect of non-dihydropyridines that reduces heart rate